CTSH vs DOCS
Cognizant Technology Solutions Corporation and Doximity, Inc., side by side — 7 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CTSH | DOCS |
|---|---|---|
| Revenue | $21.1B | $644.9M |
| Net income | $2.2B | $196.1M |
| Gross margin | — | 89.1% |
| Net margin | 10.6% | 30.4% |
| Return on equity | 15.2% | 19.3% |
| Diluted EPS | $4.56 | — |
| Dividend / share | $1.24 | — |
| Payout ratio | 27.4% | — |
| Free cash flow | $2.6B | $326.5M |
| Equity | $15.0B | $950.8M |
| Net debt / equity | −0.09× | — |
| Current ratio | 2.14× | 6.09× |
| Revenue CAGR 5y | 4.9% | 25.5% |
| Profit CAGR 5y | 9.9% | 31.3% |
CTSH bills 32.7× the revenue of DOCS, and DOCS keeps more of each dollar of revenue as profit (30.4% against 10.6%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
7 years side by side
| Fiscal year | CTSH | DOCS |
|---|---|---|
| FY2025 | $21.1B | $644.9M |
| FY2024 | $19.7B | $570.4M |
| FY2023 | $19.4B | $475.4M |
| FY2022 | $19.4B | $419.1M |
| FY2021 | $18.5B | $343.5M |
| FY2020 | $16.7B | $206.9M |
| FY2019 | $16.8B | $116.4M |
Net income by year
Bottom line
| Fiscal year | CTSH | DOCS |
|---|---|---|
| FY2025 | $2.2B | $196.1M |
| FY2024 | $2.2B | $223.2M |
| FY2023 | $2.1B | $147.6M |
| FY2022 | $2.3B | $112.8M |
| FY2021 | $2.1B | $154.8M |
| FY2020 | $1.4B | $50.2M |
| FY2019 | $1.8B | $29.7M |
Advertisement
AdSense · Rectangle 336×280
More in this industry